Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium-Reference-Cited by-同舟云学术

Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium

Published:2017-12-28 Issue:3 Volume:117 Page:363-371
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Krasnick Bradley A.¹^ORCID,Jin Linda X.¹,Davidson Jesse T.¹,Sanford Dominic E.¹,Ethun Cecilia G.²,Pawlik Timothy M.³^ORCID,Poultsides George A.⁴,Tran Thuy⁴,Idrees Kamran⁵,Hawkins William G.¹,Chapman William C.¹,Doyle Maria B.M.¹,Weber Sharon M.⁶,Strasberg Steven M.¹,Salem Ahmed⁶,Martin Robert C.G.⁷,Isom Chelsea A.⁵,Scoggins Charles⁷,Schmidt Carl R.³,Shen Perry⁸,Beal Eliza³,Hatzaras Ioannis⁹,Shenoy Rivfka⁹,Maithel Shishir K.²,Fields Ryan C.¹

Affiliation:

1. Department of Surgery; Washington University School of Medicine; St Louis Missouri

2. Winship Cancer Institute; Emory University; Atlanta Georgia

3. The Ohio State University Comprehensive Cancer Center; Columbus Ohio

4. Stanford University Medical Center; Palo Alto California

5. Vanderbilt University Medical Center; Nashville Tennessee

6. University of Wisconsin School of Medicine and Public Health; Madison Wisconsin

7. University of Louisville; Louisville Kentucky

8. Wake Forest University; Winston-Salem North Carolina

9. New York University; New York New York

Publisher

Wiley